# Interleukin-1 Blockade in HF With Preserved EF

> **NCT02173548** · PHASE2 · COMPLETED · sponsor: **Virginia Commonwealth University** · enrollment: 31 (actual)

## Conditions studied

- Heart Failure With Normal Ejection Fraction

## Interventions

- **DRUG:** Anakinra
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02173548
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2017-04-11
- **Final completion:** 2017-06-01
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2018-06-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02173548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02173548, "Interleukin-1 Blockade in HF With Preserved EF". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02173548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*